Athenex Inc - Company Profile
Powered by 
All the data and insights you need on Athenex Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Athenex Inc Strategy Report
- Understand Athenex Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Athenex Inc (Athenex) is a biopharmaceutical company focused on the discovery, development of autologous and allogeneic CAR-NKT cell therapies to treat cancers. The company's product pipeline includes KUR-501–GD2, KUR-502–CD19, KUR-503–GPC3 and p53-KRAS and EGFR. Athenex platform includes oncology innovation Platform for research and development, commercial platform for manufacturing and marketing of products and global supply chain which provide APIS to clinical and commercial effort. The company partners with pharmaceutical companies, universities and research institutions for the advancement and commercialization of its products. It has operations with product manufacturing facilities in the US, China, Taiwan and Hong Kong. Athenex is headquartered in Buffalo, New York, the US.
Headquarters
United States of America
Address
1001 Main St Ste 600, Buffalo, New York, 14203-1009
Website
www.athenex.com
Telephone
1 716 8988625
No of Employees
269
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$102.8M
Athenex Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Products Pipeline: | Clinical Development Services | Klisyri |
| NKT Cell Platform: | API Manufacturing Services | |
| Kur-501: High Risk Neuroblastoma | Drug Discovery and Formulation | |
| XYZ | ||
| XYZ | ||
| XYZ |
Competitor Comparison
| Key Parameters | Athenex Inc | TC BioPharm Ltd | CRISPR Therapeutics AG | Puma Biotechnology Inc | Editas Medicine Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United Kingdom | Switzerland | United States of America | United States of America |
| City | Buffalo | Glasgow | Zug | Los Angeles | Cambridge |
| State/Province | New York | Scotland | - | California | Massachusetts |
| No. of Employees | 269 | 69 | 407 | 185 | 265 |
| Entity Type | Private | Private | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Johnson Y.N. Lau | Chairman; Chief Executive Officer | Executive Board | 2011 | 61 |
| Joe Annoni | Chief Financial Officer | Senior Management | 2022 | 54 |
| Jeffrey Yordon | Chief Operating Officer; President - Athenex Pharmaceutical Division | Senior Management | 2017 | 74 |
| Rudolf Kwan | Medical Officer-Small Molecules | Senior Management | - | - |
| Jacqueline Li | Vice President - Alliance Management and Corporate Development; Chief Financial Officer - Axis Therapeutics | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer